AI Meets Genetic Agency at Dyno GATC 2025
BOSTON – Artificial intelligence (AI) emerged as a pivotal theme at the recent Genetic Agency…
Newswire
UK Considers Raising NICE Cost-Effectiveness Threshold Amidst Drug Spending Debate
The UK is contemplating an increase in the National Institute for Health and Care Excellence…
Bristol Myers, J&J’s new blood thinner fails first big test
Milvexian’s failure in acute coronary syndrome trials has raised significant concerns regarding the future of…
Advocates decry intersex exceptions in trans health bans
Recent legislative measures aimed at restricting transgender healthcare have sparked significant backlash, particularly concerning the…
Bristol Myers, J&J’s Next-Gen Blood Thinner Fails Key Trial in Another Setback for Factor XI
In a significant blow to the pharmaceutical industry’s efforts to develop safer anticoagulants, Bristol Myers…
Pfizer Reduces Stake in BioNTech; Candel Pauses Pancreatic Cancer Program
Pfizer has reduced its stake in BioNTech, now holding approximately $163.5 million in shares following…
Lundbeck sparks bidding war with Alkermes; Pfizer closes Metsera deal
Pfizer has finalized a $10 billion acquisition of Metsera, decisively outbidding Novo Nordisk in a…
MSD bets big on flu antivirals with $9.2bn buyout of Cidara
MSD has announced a significant $9.2 billion acquisition of Cidara Therapeutics, marking its second major…
FDA restricts Sarepta’s gene therapy Elevidys after Duchenne patient deaths
The FDA has imposed new restrictions on Sarepta Therapeutics’ gene therapy, Elevidys, following reports of…
NIH Places Outspoken Critic of Trump Administration on Leave
A vocal critic of the Trump administration’s policies at the National Institutes of Health (NIH)…